Skip to Content

E50 (Etoposide 50 mg)

Pill with imprint E50 is Pink, Capsule-shape and has been identified as Etoposide 50 mg. It is supplied by Mylan Pharmaceuticals Inc..

Etoposide is used in the treatment of small cell lung cancer; ovarian cancer; testicular cancer; cancer; hodgkin's lymphoma and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for E50

Etoposide

Imprint
E50
Strength
50 mg
Color
Pink
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Mitotic inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-3266
Inactive Ingredients
citric acid anhydrous, glycerin, polyethylene glycol, gelatin, ferric oxide red, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 40, hypromelloses, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "E50"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.